Medway school of pharmacy

Iain graduated from The Robert Gordon University (RGU) in 1981 and completed his pre-registration training at Aberdeen Royal Infirmary in 1982. He gained his initial pharmaceutical industry experience working for Napp Laboratories in Cambridge. Iain then had a lecturing post in pharmaceutics and drug delivery at RGU 1988-1994, where he also completed a PhD in pharmaceutics in the area of transdermal research. This was followed by a very enjoyable time at Elan Corporation, Ireland, bringing new R&D products to market and managing the science of numerous global Joint Ventures in multiple fields.

Prior to becoming Head of School at Medway in August 2007, Iain was Vice President for R&D and Quality for IVAX Europe, a major generic pharmaceutical company.

back to top

Professor Cumming’s major research interests are focused on pharmaceutics and drug delivery systems. Particular areas include transdermal, controlled release, pulmonary, and nanoparticulate drug delivery systems and their application to pharmaceutical products. He also has an interest in the development of methods to improve bioavailability of drugs with low aqueous solubility.

back to top

Selected Publications

• Raoof AA, Chiu P, Ramtoola Z, Cumming KI, Teng C, Weinbach SP, Hardee G, Levin AA, Geary RS (2004). Oral bioavailability and multiple dose tolerability of an antisense oilgoneucleotide tablet formulated with sodium caprate. J. Pharm. Sci. 93: No 6, 1431-1439.
• Leane MM, Cumming KI, Corrigan OI (2003). The use of artificial neural networks for the selection of the most appropriate formulation and processing variables in order to predict the in-vitro dissolution of sustained release minitablets. AAPS PharmSciTech 4(2) Article 26.
• Palaniswamy S, Rekhi GS, Sackett GL, Cumming KI (2002). Evaluation of granurex coater for multiparticulate coating. AAPS PharmSci. 4 (S1) T3316.
• Wilson AW, Ramtoola Z, Conaghey O, McGoldrick CA, Hou SY, Cumming KI (2002). Pharmacoscintigraphic evaluation of a novel controlled release (Endogastric Therapeutic System) for gastric retention in healthy volunteers. AAPS PharmSci. 4 (S1) T3274.
• Dresser GK, Wacher VJ, Ramtoola Z, Cumming KI, Bailey DG (2002). Peppermint oil increases the oral bioavailability of felodipine and simvastatin. Clin. Pharmacol. Ther. 71 (2).

Patents

• Clancy MJA, Caulfield M, Cumming KI, (2002).Controlled release pharmaceutical compositions containing tiagabine. U.S. 6,3999,100.
• Jain RA, Ruddy SB, Cumming KI, Clancy MJA, Codd JE (2001). Rapidly disintegrating solid oral dosage forms. U.S. 6,316,029.
• Cumming KI, Harris E, (2000). Taste-masked formulations. U.S. 6,153,220.

back to top